Aldomet and Occlusion - renal artery - a phase IV clinical study of FDA data


Occlusion - renal artery is found among people who take Aldomet, especially for people who are male, 0-1 old.

The phase IV clinical study analyzes which people take Aldomet and have Occlusion - renal artery. It is created by eHealthMe based on reports of 2,225 people who have side effects when taking Aldomet from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Jan, 29, 2023

2,225 people reported to have side effects when taking Aldomet.
Among them, 10 people (0.45%) have Occlusion - renal artery.

What is Aldomet?

Aldomet has active ingredients of methyldopa. It is often used in high blood pressure. eHealthMe is studying from 2,292 Aldomet users for its effectiveness, alternative drugs and more.

What is Occlusion - renal artery?

Occlusion - renal artery (a blockage of the major arteries that supply blood to the kidneys) is found to be associated with 1,225 drugs and 704 conditions by eHealthMe.

Number of Aldomet and Occlusion - renal artery reports submitted per year:

Could Aldomet cause Occlusion - renal artery?

Gender of people who have Occlusion - renal artery when taking Aldomet *:

  • female: 50 %
  • male: 50 %

Age of people who have Occlusion - renal artery when taking Aldomet *:

  • 0-1: 55.56 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 0.0 %
  • 60+: 44.44 %

Common drugs people take besides Aldomet *:

  1. Diovan: 5 people, 50.00%
  2. Abilify: 4 people, 40.00%
  3. Lasix: 4 people, 40.00%
  4. Lopressor: 3 people, 30.00%
  5. Pletal: 3 people, 30.00%
  6. Allopurinol: 2 people, 20.00%
  7. Amitiza: 1 person, 10.00%
  8. Amlodipine: 1 person, 10.00%
  9. Ativan: 1 person, 10.00%
  10. Coumadin: 1 person, 10.00%

Common side effects people have besides Occlusion - renal artery *:

  1. Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 5 people, 50.00%
  2. Foetal Exposure During Pregnancy (exposing your unborn child to contraindicated in pregnancy leads birth defect): 4 people, 40.00%
  3. Hypertrophic Cardiomyopathy (a condition in which the heart muscle becomes abnormally thick): 4 people, 40.00%
  4. White Blood Cell Count Increased: 2 people, 20.00%
  5. Lymphocyte Count Decreased: 2 people, 20.00%
  6. Blood Calcium Increased: 2 people, 20.00%
  7. Blood Creatinine Increased: 2 people, 20.00%
  8. Blood Iron Decreased: 2 people, 20.00%
  9. Blood Urea Increased: 2 people, 20.00%
  10. Blood Uric Acid Increased: 2 people, 20.00%

Common conditions people have *:

  1. Bipolar Disorder (mood disorder): 4 people, 40.00%
  2. Type 2 Diabetes: 1 person, 10.00%
  3. Rotator Cuff Syndrome (a spectrum of conditions affecting the rotator cuff tendons of the shoulder): 1 person, 10.00%
  4. Nephrogenic Anaemia (anaemia due to kidney disease): 1 person, 10.00%
  5. Hypozincaemia (the condition of having insufficient zinc in the body): 1 person, 10.00%
  6. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 1 person, 10.00%
  7. Hyperuricaemia (level of uric acid in the blood that is abnormally high): 1 person, 10.00%
  8. Hyperkalemia (damage to or disease of the kidney): 1 person, 10.00%
  9. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 10.00%
  10. Dyslipidaemia (abnormal amount of lipids): 1 person, 10.00%

* Approximation only. Some reports may have incomplete information.

Do you take Aldomet and have Occlusion - renal artery?

Check whether Occlusion - renal artery is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

How severe was Occlusion - renal artery and when was it recovered:

Expand to all the drugs that have ingredients of methyldopa:

Alternative drugs to, pros and cons of Aldomet:

Common Aldomet side effects:

Browse all side effects of Aldomet:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Occlusion - renal artery treatments and more:

COVID vaccines that are related to Occlusion - renal artery:

Common drugs associated with Occlusion - renal artery:

All the drugs that are associated with Occlusion - renal artery:

Common conditions associated with Occlusion - renal artery:

All the conditions that are associated with Occlusion - renal artery:

How the study uses the data?

The study uses data from the FDA. It is based on methyldopa (the active ingredients of Aldomet) and Aldomet (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).


WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: